Bonus BioGroup Ltd. (BBIXF)

OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0299 (-99.67%)
At close: May 22, 2025
-99.75%
Market Cap 73.64M
Revenue (ttm) n/a
Net Income (ttm) -7.64M
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 173
Average Volume 6,774
Open 0.0001
Previous Close 0.0300
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0500
Beta 0.89
RSI 38.02
Earnings Date May 29, 2025

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products in development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase II... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 49
Stock Exchange OTCMKTS
Ticker Symbol BBIXF
Full Company Profile

Financial Performance

Financial numbers in ILS Financial Statements

News

There is no news available yet.